These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 12875302)
1. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies. Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302 [TBL] [Abstract][Full Text] [Related]
2. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico. Oberste MS; Fraire M; Navarro R; Zepeda C; Zarate ML; Ludwig GV; Kondig JF; Weaver SC; Smith JF; Rico-Hesse R Am J Trop Med Hyg; 1998 Jul; 59(1):100-7. PubMed ID: 9684636 [TBL] [Abstract][Full Text] [Related]
3. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines. Ferguson JA; Reeves WC; Hardy JL Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275 [TBL] [Abstract][Full Text] [Related]
4. A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses. Wang E; Paessler S; Aguilar PV; Smith DR; Coffey LL; Kang W; Pfeffer M; Olson J; Blair PJ; Guevara C; Estrada-Franco J; Weaver SC Am J Trop Med Hyg; 2005 Jun; 72(6):805-10. PubMed ID: 15964967 [TBL] [Abstract][Full Text] [Related]
5. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
6. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002 [TBL] [Abstract][Full Text] [Related]
7. Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program. Monath TP; Sabattini MS; Pauli R; Daffner JF; Mitchell CJ; Bowen GS; Cropp CB Am J Trop Med Hyg; 1985 Sep; 34(5):966-75. PubMed ID: 2863991 [TBL] [Abstract][Full Text] [Related]
8. Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains. Wang E; Bowen RA; Medina G; Powers AM; Kang W; Chandler LM; Shope RE; Weaver SC; Am J Trop Med Hyg; 2001 Jul; 65(1):64-9. PubMed ID: 11504410 [TBL] [Abstract][Full Text] [Related]
9. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110 [TBL] [Abstract][Full Text] [Related]
10. Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics. Gonzalez-Salazar D; Estrada-Franco JG; Carrara AS; Aronson JF; Weaver SC Emerg Infect Dis; 2003 Feb; 9(2):161-8. PubMed ID: 12603985 [TBL] [Abstract][Full Text] [Related]
11. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
12. Association of Tonate virus (subtype IIIB of the Venezuelan equine encephalitis complex) with encephalitis in a human. Hommel D; Heraud JM; Hulin A; Talarmin A Clin Infect Dis; 2000 Jan; 30(1):188-90. PubMed ID: 10619752 [TBL] [Abstract][Full Text] [Related]
13. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone. Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; AƱez F Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268 [TBL] [Abstract][Full Text] [Related]
14. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. Brault AC; Powers AM; Holmes EC; Woelk CH; Weaver SC J Virol; 2002 Feb; 76(4):1718-30. PubMed ID: 11799167 [TBL] [Abstract][Full Text] [Related]
15. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Weaver SC; Salas R; Rico-Hesse R; Ludwig GV; Oberste MS; Boshell J; Tesh RB Lancet; 1996 Aug; 348(9025):436-40. PubMed ID: 8709783 [TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Charles PC; Trgovcich J; Davis NL; Johnston RE Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219 [TBL] [Abstract][Full Text] [Related]
18. Potential for Central American mosquitoes to transmit epizootic and enzootic strains of Venezuelan equine encephalitis virus. Turell MJ; Barth J; Coleman RE J Am Mosq Control Assoc; 1999 Sep; 15(3):295-8. PubMed ID: 10480118 [TBL] [Abstract][Full Text] [Related]
19. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Ferguson JA; Reeves WC; Milby MM; Hardy JL Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386 [TBL] [Abstract][Full Text] [Related]
20. Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico. Oberste MS; Schmura SM; Weaver SC; Smith JF Am J Trop Med Hyg; 1999 Apr; 60(4):630-4. PubMed ID: 10348239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]